コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 p a vaccine against cytomegalovirus (CMV), a canarypox virus (ALVAC) expressing CMV glycoprotein (gB)
2 cells, might be immunogenic, we studied how canarypox virus (ALVAC) interacts with primate antigen-p
3 ge with attenuated vaccinia virus (NYVAC) or canarypox virus (ALVAC) vaccine strains expressing the C
4 oxviruses, including vaccinia virus (VV) and canarypox virus (ALVAC), do not indiscriminately infect
6 ature DCs resisted the cytopathic effects of canarypox virus and elicited strong effector CD8+ T-cell
7 pro, and env coding sequences was placed in canarypox virus and MVA vector backbones in order to dir
8 identified homologs found in the fowlpox and canarypox viruses and the previously cloned mammalian DN
9 teins produced by African swine fever virus, Canarypox virus, and Herpes simplex virus to promote eIF
12 ross mucosal barriers, a randomized trial of canarypox virus-based vectors was conducted in 84 indivi
14 e responses to HCV DNA prime and recombinant canarypox virus boost were also studied with the above c
15 t 10 months postimmunization (8 months after canarypox virus boost), the protection in HCV DNA prime/
18 after a canarypox virus boost, the DNA prime/canarypox virus boosting regimen induced potent cellular
20 nded in the avipoxviruses (31 in FWPV; 51 in canarypox virus [CNPV], representing 15% of the total ge
21 lizing antibody and CD4+ T cell help, a live canarypox virus construct expressing gp120, transmembran
24 rotein 1 (PkMSP1p42), as well as recombinant canarypox viruses encoding the four antigens (ALVAC-4).
25 ts who were vaccinated with live recombinant canarypox virus expressing human immunodeficiency virus
26 In this study, the ability of a recombinant canarypox virus expressing SIV Gag-Pol-Env (ALVAC/SIV ga
27 201(+) monkeys vaccinated with a recombinant canarypox virus-HIV-1 env construct also demonstrated p4
28 2 months postimmunization, the HCV DNA prime/canarypox virus-immunized mice showed a complete reducti
29 own to be greater than that from recombinant canarypox virus in the mammalian cell lines and in the p
34 o enhance these responses would be to target canarypox virus to professional antigen-presenting cells
39 ction, we administered vaccines containing a canarypox virus vector, vCP1452, with HIV-1 genes encodi
42 refore, these results suggest that targeting canarypox virus vectors to mature DCs could potentially
43 HIV-1-specific (vCP 205) and rabies (vCP 65) canarypox virus vectors were delivered systemically and/
44 the doses and routes of administration used, canarypox virus was not an effective mucosal immunogen.
45 of vaccinia virus and in the ALVAC strain of canarypox virus, which does not productively replicate i
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。